PRGO - Perrigo Company plc

NYSE - NYSE Delayed Price. Currency in USD
46.18
+0.51 (+1.12%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close45.67
Open46.17
Bid43.66 x 1000
Ask48.00 x 1100
Day's Range45.67 - 46.76
52 Week Range36.28 - 78.90
Volume1,700,289
Avg. Volume1,256,995
Market Cap6.283B
Beta (3Y Monthly)1.94
PE Ratio (TTM)72.27
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.84 (1.84%)
Ex-Dividend Date2019-08-29
1y Target EstN/A
Trade prices are not sourced from all markets
  • Does Perrigo (NYSE:PRGO) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Perrigo (NYSE:PRGO) Have A Healthy Balance Sheet?

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

  • Thomson Reuters StreetEvents

    Edited Transcript of PRGO earnings conference call or presentation 8-Aug-19 12:00pm GMT

    Q2 2019 Perrigo Company PLC Earnings Call

  • PetIQ, Inc. (PETQ) Q2 2019 Earnings Call Transcript
    Motley Fool

    PetIQ, Inc. (PETQ) Q2 2019 Earnings Call Transcript

    PETQ earnings call for the period ending June, 30, 2019.

  • PRGO vs. BIO: Which Stock Is the Better Value Option?
    Zacks

    PRGO vs. BIO: Which Stock Is the Better Value Option?

    PRGO vs. BIO: Which Stock Is the Better Value Option?

  • Perrigo (PRGO) Q2 2019 Earnings Call Transcript
    Motley Fool

    Perrigo (PRGO) Q2 2019 Earnings Call Transcript

    PRGO earnings call for the period ending June 30, 2019.

  • Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up
    Zacks

    Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up

    Perrigo (PRGO) reports encouraging second-quarter 2019 results. The Rx segment recovers on strong new product sales.

  • TheStreet.com

    Perrigo Beats Second-Quarter Estimates but Stock Tumbles

    Perrigo is falling despite beating Wall Street's second-quarter earnings and revenue expectations.

  • Perrigo (PRGO) Tops Q2 Earnings and Revenue Estimates
    Zacks

    Perrigo (PRGO) Tops Q2 Earnings and Revenue Estimates

    Perrigo (PRGO) delivered earnings and revenue surprises of 6.17% and 1.58%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Benzinga

    Perrigo Reports Q2 Earnings, Reaffirms Guidance

    Perrigo Co (NYSE: PRGO) reported second-quarter earnings of 86 cents per share, which beat the analyst consensus estimate of 79 cents by 8.86%. The company reported quarterly sales of $1.127 billion, which missed the analyst consensus estimate of $1.13 billion by 0.27%.

  • MarketWatch

    Perrigo's stock surges after profit and revenue decline less than expected, outlook affirmed

    Shares of Perrigo Co. surged 6.0% in premarket trading Thursday, after the over-the-counter health and wellness products company reported second-quarter profit and revenue that beat expectations, and affirmed its full-year outlook. Net income fell to $9 million, or 7 cents a share, from $36 million, or 26 cents a share, in the year-ago period. Excluding non-recurring items, adjusted EPS fell to 86 cents from $1.22, above the FactSet consensus of 79 cents. Sales declined 3.1% to $1.15 billion but topped the FactSet consensus of $1.13 billion, as consumer self-care America sales fell 2.5%, consumer self-care international sales declined 8.5% and prescription pharmaceuticals sales rose 3.4%. The company affirmed its 2019 adjusted EPS outlook of $3.75 to $4.05. The stock has run up 30.3% year to date through Wednesday, while the S&P 500 has gained 15.0%.

  • Benzinga

    Q2 Earnings Preview For Perrigo

    Perrigo Co (NYSE: PRGO ) releases its next round of earnings this Thursday, August 8. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report. Earnings and Revenue ...

  • What's in the Cards for Perrigo (PRGO) This Earnings Season?
    Zacks

    What's in the Cards for Perrigo (PRGO) This Earnings Season?

    Perrigo (PRGO) is focused on Consumer Self Care Americas segment. It remains to be seen if this benefits the company's results in the soon-to-be reported quarter.

  • Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

    Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • PRGO or SRDX: Which Is the Better Value Stock Right Now?
    Zacks

    PRGO or SRDX: Which Is the Better Value Stock Right Now?

    PRGO vs. SRDX: Which Stock Is the Better Value Option?

  • Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 45% Undervaluation?
    Simply Wall St.

    Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 45% Undervaluation?

    Today we will run through one way of estimating the intrinsic value of Perrigo Company plc (NYSE:PRGO) by taking the...

  • S&P 500 index tops 3,000 for first time — here’s how the stock market got here and what it means
    MarketWatch

    S&P 500 index tops 3,000 for first time — here’s how the stock market got here and what it means

    Five years in the making. That is essentially the time it has taken for the S&P 500 to hit a milestone mark at 3,000 for the first time in its history. The stock gauge first closed at 2,000 on Aug. 26, 2014, according to Dow Jones Market Data.

  • Markit

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    Perrigo Company PLC NYSE:PRGOView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate and increasing * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for PRGO with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on June 24. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.32 billion over the last one-month into ETFs that hold PRGO are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Perrigo Completes Ranir Acquisition, Raises '19 Guidance
    Zacks

    Perrigo Completes Ranir Acquisition, Raises '19 Guidance

    Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.

  • MarketWatch

    Perrigo shares up 1.5% after FDA approves marketing application for generic antibacterial

    Shares of Dublin-based Perrigo Co. Plc rose 1.5% in premarket trade Wednesday after the company said the U.S. Food and Drug Administration had approved a development partner's marketing application for a generic version of Metrogel-Vaginal, a treatment for bacterial vaginosis. The generic was developed in partnership with Capstone Development Solutions, a unit of Water Street Healthcare Partners, and Perrigo will get full ownership of the application within the next 30 days. Annual market sales for Metrogel-Vaginal for the 12 months ending May 2019 were around $100 million, Perrigo said, and the company plans to start selling the drug immediately after getting ownership of the application. Shares of the company have gained 27.4% in the year to date through Tuesday, while the S&P 500 has gained 18.6%.

  • Benzinga

    Perrigo Adjusts Guidance After Acquiring Ranir Global For $750M

    Perrigo Company (NYSE: PRGO ) has acquired Ranir Global Holdings, a supplier of oral self-care products for $750 million in cash. Perrigo also adjusted its FY2019 earnings guidance, from $3.75-$4.05 including ...

  • MarketWatch

    Perrigo shares up 2% after company boosts adjusted full-year EPS guidance by 10 cents

    Shares of Perrigo Co. Plc rose 2% in premarket trade Tuesday after the company raised its adjusted full-year EPS guidance to between $3.75 and $4.05 from between $3.65 and $3.95. The Dublin-based pharmaceutical company said the 10-cent boost came from its $750 million cash acquisition of oral-care products company Ranir Global Holdings LLC, which Perrigo said had successfully closed. Shares of Perrigo have gained 25% in the year to date through Monday, while the S&P 500 has gained 18.3%.

  • Pharmacy Stocks Rise on News Amazon is Backing Off
    Investopedia

    Pharmacy Stocks Rise on News Amazon is Backing Off

    Pharmacy stocks got a lift in trading Monday after CNBC reported Amazon is backing off of selling drugs to hospitals.

  • Here’s What Hedge Funds Think About Perrigo Company plc (PRGO)
    Insider Monkey

    Here’s What Hedge Funds Think About Perrigo Company plc (PRGO)

    Is Perrigo Company plc (NYSE:PRGO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage […]

  • Would Perrigo Company plc (NYSE:PRGO) Be Valuable To Income Investors?
    Simply Wall St.

    Would Perrigo Company plc (NYSE:PRGO) Be Valuable To Income Investors?

    Dividend paying stocks like Perrigo Company plc (NYSE:PRGO) tend to be popular with investors, and for good reason...